Physician profile
Chandler Robert Mann
NPI 1447812284
$48,588.36
in general payments reported to CMS, 2019-2025
21 companies · $37K in 2025
The $37K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2021: $103 · 2022: $1,795 · 2023: $2,414 · 2024: $6,770 · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Travel and Lodging: $6,610 · Gift: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27,836.10 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11,700.00 |
| Travel and Lodging | $6,609.97 |
| Gift | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $22,328.39 | 2025 | M22 |
| Coopervision INC. | $19,926.39 | 2023-2025 | Misight Contact Lens, Coopervision Contact Lens, Cvi Contact Lens |
| Johnson & Johnson Vision Care, INC. | $2,077.04 | 2022-2025 | Acuvue |
| Alcon Vision LLC | $823.55 | 2021-2025 | Total30, Precision7, Precision 1 |
| Visionary Optics LLC | $650.00 | 2022-2024 | |
| Bausch & Lomb Americas INC. | $544.37 | 2022-2025 | Infuse, Biotrue, Biotrue One Day |
| Abbvie INC. | $455.35 | 2022-2023 | |
| Allergan, INC. | $288.38 | 2021-2022 | |
| Glaukos Corporation | $280.58 | 2022-2025 | Idosetr |
| Topcon Healthcare, INC. | $184.21 | 2023-2024 | |
| Lkc Technologies, INC. | $173.41 | 2022-2025 | |
| Eyevance Pharmaceuticals LLC | $166.67 | 2019 | |
| Novartis Pharmaceuticals Corporation | $159.68 | 2021-2022 | |
| Sight Sciences, INC. | $141.92 | 2024-2025 | Tearcare System |
| Biotissue Holdings INC. | $135.07 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $97.56 | 2022-2023 | Tyrvaya |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $61.39 | 2019-2021 | |
| Astellas Pharma US INC | $31.01 | 2024 | Izervay |
| Sun Pharmaceutical Industries INC. | $28.82 | 2019-2023 | Cequa |
| Thea Pharma INC. | $17.48 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $17.09 | 2024 | Cirrus Hd-Oct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandler Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.